KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Depreciation & Amortization - TotalEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Non-Controlling InterestsInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

National Health Investors (NHI) Depreciation & Amortization - Total (2016 - 2025)

National Health Investors (NHI) has disclosed Depreciation & Amortization - Total for 17 consecutive years, with $20.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Depreciation & Amortization - Total rose 13.78% year-over-year to $20.2 million, compared with a TTM value of $59.3 million through Dec 2025, down 17.01%, and an annual FY2024 reading of $71.4 million, up 2.1% over the prior year.
  • Depreciation & Amortization - Total was $20.2 million for Q3 2025 at National Health Investors, up from $19.9 million in the prior quarter.
  • Across five years, Depreciation & Amortization - Total topped out at $20.8 million in Q1 2021 and bottomed at $17.1 million in Q4 2023.
  • Average Depreciation & Amortization - Total over 5 years is $18.5 million, with a median of $17.8 million recorded in 2022.
  • The sharpest move saw Depreciation & Amortization - Total dropped 13.97% in 2022, then grew 13.88% in 2025.
  • Year by year, Depreciation & Amortization - Total stood at $19.3 million in 2021, then fell by 10.34% to $17.3 million in 2022, then dropped by 1.11% to $17.1 million in 2023, then grew by 9.17% to $18.7 million in 2024, then grew by 8.22% to $20.2 million in 2025.
  • Business Quant data shows Depreciation & Amortization - Total for NHI at $20.2 million in Q3 2025, $19.9 million in Q2 2025, and $19.2 million in Q1 2025.